Leadership Appointment at Poly Medicure
Poly Medicure Limited (NSE: POLYMED), a manufacturer of medical disposables and capital equipment, has announced the appointment of Mr. Indranil Mukherjee as Chief Executive Officer for its Asia Pacific and India Business operations. The appointment becomes effective June 1, 2026. Mukherjee will join the company as Senior Management Personnel, overseeing business strategy and operations across the region.
About the New CEO
Mr. Indranil Mukherjee assumes the newly structured leadership role at Poly Medicure, one of India's prominent medical device manufacturers. The position encompasses responsibility for the company's commercial performance in the Asia Pacific corridor alongside domestic operations in India.
The appointment signals Poly Medicure's focus on strengthening its executive leadership as the company continues to serve healthcare institutions domestically and internationally.
About Poly Medicure Limited
Poly Medicure Limited is listed on the National Stock Exchange under the symbol POLYMED. The company operates manufacturing facilities across multiple locations and produces a range of medical devices including IV Cannulas, Surgical Sutures, Urine Containers, and Blood Collection Tubes. The company also manufactures pathology lab equipment and other hospital consumables.
Poly Medicure exports its products to over 120 countries, serving healthcare systems worldwide. The company maintains its registered office in India and operates as a dedicated medical devices manufacturer within the healthcare sector.
Significance of the Appointment
The creation of a dedicated CEO position for the Asia Pacific and India Business reflects the growing importance of these markets within Poly Medicure's overall portfolio. As the medical devices industry continues to evolve, leadership appointments at the senior management level often indicate strategic priorities for regional growth.
Stakeholders and investors tracking POLYMED on the NSE should monitor the company's official communications for additional context regarding this leadership transition and any further updates on the appointment.
This announcement represents a senior management personnel change at Poly Medicure Limited. For complete details and official statements, investors are advised to refer to the company's filings with the stock exchanges.